Suppr超能文献

肝硬化患者对人类真菌病原体 的协调中性粒细胞反应丧失。

Loss of Coordinated Neutrophil Responses to the Human Fungal Pathogen, , in Patients With Cirrhosis.

机构信息

Department of MedicineMassachusetts General HospitalBostonMAUSA.

Harvard Medical SchoolBostonMAUSA.

出版信息

Hepatol Commun. 2021 Jan 5;5(3):502-515. doi: 10.1002/hep4.1645. eCollection 2021 Mar.

Abstract

Neutrophils are the most abundant white blood cell in the body and are key participants in the defense against fungal infections. Fungal infections occur often in patients with cirrhosis and are associated with increased 30-day and 90-day mortality. Previous studies have shown that specific neutrophil functions are abnormal in patients with cirrhosis, although the extent of neutrophil dysfunction is not well understood. We tested the ability of neutrophils from 21 hospitalized patients with cirrhosis and 23 healthy control patients to kill , a common fungal pathogen in patients with cirrhosis. Using an assay, we also measured the ability of neutrophils to coordinate multicellular, synchronized control of hyphae through a process known as swarming. We found that neutrophils from patients with cirrhosis have significantly decreased fungicidal capacity compared with healthy control neutrophils (53% vs. 74%,  < 0.0001) and diminished ability to control hyphal growth normalized as a ratio to healthy control (0.22 vs. 0.65,  < 0.0001). Moreover, serum from patients with cirrhosis decreases the ability of healthy control neutrophils to kill (from 60% to 41%,  < 0.003). Circulating concentration of the inflammatory cytokines tumor necrosis factor α, interleukin-6, and interleukin-8 were found to be significantly elevated in patients with cirrhosis compared to healthy controls. Following pretreatment with granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor, neutrophil function was restored to almost that of healthy controls. Our data establish profound neutrophil dysfunction against, and altered swarming to, in patients with cirrhosis. This dysfunction can be partially reversed with cytokine augmentation .

摘要

中性粒细胞是体内数量最多的白细胞,是抵御真菌感染的关键参与者。肝硬化患者常发生真菌感染,且与 30 天和 90 天死亡率增加相关。既往研究表明,肝硬化患者特定的中性粒细胞功能异常,尽管中性粒细胞功能障碍的程度尚不清楚。我们检测了 21 名住院肝硬化患者和 23 名健康对照者的中性粒细胞杀死常见肝硬化患者病原体的能力。我们使用一种检测方法,还测量了中性粒细胞通过一种称为群体感应的过程协调多细胞同步控制菌丝生长的能力。我们发现,与健康对照者的中性粒细胞相比,肝硬化患者的中性粒细胞的杀菌能力显著降低(53%比 74%, <0.0001),且控制菌丝生长的能力也降低,以与健康对照者的比值表示(0.22 比 0.65, <0.0001)。此外,肝硬化患者的血清降低了健康对照者中性粒细胞杀死 的能力(从 60%降至 41%, <0.003)。与健康对照者相比,我们发现肝硬化患者的循环炎症细胞因子肿瘤坏死因子-α、白细胞介素-6 和白细胞介素-8 的浓度明显升高。经粒细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子预处理后,中性粒细胞功能恢复到接近健康对照者的水平。我们的数据确立了肝硬化患者针对 和菌丝感应的严重中性粒细胞功能障碍。这种功能障碍可以通过细胞因子增强部分逆转。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6caa/7917271/5b3aa0cfca87/HEP4-5-502-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验